what is the difference of semaglutide and tirzepatide Comparative safety side effects and tirzepatide: Implications for clinical decision-making in obesity management Tirzepatide vs. Ozempic: Comparing Diabetes

Approximately half of all patients who begin taking these drugs discontinue their use within the first year, however, and three-quarters have stopped after two years

Patients with higher starting weights sometimes require doses in the 2.02.4 milligram range to achieve appetite suppression, while others see optimal results at 1.01.5 milligrams

No unexpected safety issues have arisen to date, and the established safety profile for semaglutide is similar to that of other GLP-1RAs where definitive conclusions for pancreatic and thyroid cancer cannot be drawn at this point due to low incidence of these conditions

But knowing about additives helps you understand exactly what you are injecting

To view or add a comment, sign in Audited another WebMD article